Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Интернет]. 27. Фебруар 2025. [цитирано 24. Август 2026.];3(1). Available at: https://shmpublisher.com/index.php/johmpe/article/view/547